These ASX shares have quadrupled in value in 12 months

As I mentioned earlier today, the All Ordinaries (Index: ^AXAO) (ASX: XAO) has had a tricky 12 months that has resulted in a paltry gain of just 2.5%.

The good news for investors is that there has been a good number of shares that have vastly outperformed the index.

Three which have more than quadrupled in value over the last 12 months are listed below. Here’s why they are up over 300% during this time:

The Bubs Australia Ltd (ASX: BUB) share price has climbed a massive 324% since this time last year. The fledgling goat’s milk infant formula company certainly has come a long way during this time. It has signed countless distribution agreements with supermarkets and pharmacies in Australia and several large Chinese e-commerce platforms. Of all the up and coming infant formula companies, I think Bubs would have the best chance of succeeding due to differentiating from the competition with its goat’s milk offering. However, I can’t help but feel that a significant amount of success has already been built into its share price. This makes it a reasonably risky play and subject to sharp declines if its growth is slower than expected.

The Cann Group Ltd (ASX: CAN) share price has rocketed 379% over the last 12 months. The medicinal cannabis company has been seen as one of the leaders in the growing industry due to the licences it has attained and its huge Northern and Southern facilities in Victoria. These have significant capacity and put the company in a great position to profit from the recent changes in regulations to allow for medicinal cannabis exports. That is of course if the demand for product is there. It is early days, but I have Cann Group on my watchlist.

The Ltd (ASX: KGN) share price has risen a remarkable 420% during the last 12 months after the e-commerce company continued to outperform expectations. Last month Kogan reported a 45.7% increase in first-half revenue to $209.6 million and a whopping 118.9% increase in half-year net profit after tax to $8.1 million. Incredibly, this meant that Kogan’s first-half profit alone was 12.5% higher than the total profit it made in the whole of FY 2017. While its shares are expensive, I think Kogan’s growth profile arguably justifies this premium. I would class Kogan as a buy even after this incredible gain.

Lastly, looking for the next shares to rocket higher? My money would be on these hot stocks.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.